Biologics Conjugation Scientist - Lab Start-Up; Hybrid
Listed on 2026-10-31
-
Research/Development
Research Scientist -
Healthcare
Scorpion Therapeutics seeks a Senior Scientist in Biologics Conjugation Commercialization to establish and optimize lab scale-down models and startup conjugation processes for biologics. The role requires leading laboratory operations, ensuring GMP compliance, and collaborating across functions to support late-stage biologics development.
The candidate should have expertise in conjugation chemistry, process development, and experience with biologics scale-up, with a hybrid work setup and travel
We are seeking a motivated Biologics Conjugation Scientist
- Lab Start-Up (Hybrid) to join Merck in PA, United States.
This opportunity is part of our work in Bio & Pharmacology & Health, Other.
The advertised compensation is 130..
We aim to respond to suitable candidates as soon as possible.
Full responsibilities and requirements are described in the listing above.
Learn more about the Biologics Conjugation Scientist
- Lab Start-Up (Hybrid) role in the description above.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).